Showing results (61-70 of 236) with videos related to

Sort By:
Pageof 24
BMC Infectious Diseases|August 30, 2002
Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis CRaffaele Bruno, Paolo Sacchi, Massimo Puoti, et al.
Antiviral Therapy|November 13, 2004
The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?Massimo Puoti, Alessandro Cozzi-Lepri, Fausto Ancarani, et al.
The New Microbiologica|May 18, 2017
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016Andrea Antinori, Antonio Di Biagio, Simone Marcotullio, et al.
The Journal of Antimicrobial Chemotherapy|June 9, 2016
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ARTNicola Squillace, Patrizia Lorenzini, Giuseppe Lapadula, et al.
BMC Infectious Diseases|February 14, 2014
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation studyGiulia Marchetti, Alessandro Cozzi-Lepri, Camilla Tincati, et al.
Antibiotics (Basel, Switzerland)|August 29, 2024
Cefiderocol-Based Regimen for Acinetobacter NDM-1 OutbreakGiovanna Travi, Francesco Peracchi, Marco Merli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
Optimization of hepatitis C virus screening strategies by birth cohort in ItalyLoreta A Kondili, Ivane Gamkrelidze, Sarah Blach, et al.
World Journal of Gastroenterology|June 15, 2007
Impact of hepatitis C virus infection on lifestylePaola Scognamiglio, Vincenzo Galati, Assunta Navarra, et al.
Journal of Viral Hepatitis|February 11, 2023
Impact of treatment with direct-acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co-infected individualsRoberto Rossotti, Marco Merli, Chiara Baiguera, et al.
HIV Clinical Trials|December 26, 2002
Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal studyAndrea Patroni, Carlo Torti, Lina Tomasoni, et al.
Pageof 24